Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.
暂无分享，去创建一个
R. Schilsky | F. Meric-Bernstam | M. von Mehren | W. Urba | C. Calfa | S. Halabi | M. Livingston | H. Duvivier | T. Cannon | D. Behl | Dominique C. Hinshaw | M. Rothe | G. N. Grantham | S. Powell | P. Mangat | John C Krauss | Abigail Gregory | E. Garrett-Mayer | Rodolfo Gutierrez | Eugene R Ahn | Christopher M Reynolds | H. Kaplan | Manish R Sharma